【ChiCTR1800019706】Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial
ChiCTR1800019706
尚未开始
/
/
/
2018-11-24
/
/
兒童哮喘
Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial
Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial
1. To determine the effectiveness of the multimedia education programme on improving asthma childrens health outcomes; 2. To determine the effectiveness of the multimedia education programme on enhancing parents KAP on asthma.
随机平行对照
卫生服务研究
The potential participants will be randomly allocated to either the intervention or control group in equal probability to reduce the bias on this new method of intervention. Group assignments will be placed in sealed, opaque and identical envelopes at a randomised order to maintain the allocation concealment.
Single blind
NA
/
56
/
2018-12-01
2019-09-30
/
Children: 1. A child between 4–11 years old; 2.A child admitted for asthma (ICD-10) or recurrent wheezing (more than two episodes in the last year) regardless if the diagnosis is initial or recurrent. Parent: 1. Parent with a child between 4 and 11 years old who is admitted for asthma or wheezing attack during the study period.;
请登录查看Children: 1. Chronic lung disease, such as bronchopulmonary dysplasia, which will confound the lung function assessment; 2. Developmental delay; 3. Cannot communicate in Cantonese and understand Chinese; 4. Participation in similar study; This study will exclude children aged 0 to 3 years old because making a certain diagnosis of asthma is difficult for young children given that wheezing or cough symptoms are common even for those who do not have asthma (Pedersen et al., 2011). Furthermore, adolescents (aged 12 to 17 years old) pose significant differences in cognitive ability compared with young children. They will have different delivery approaches to health education. Thus, children aged 12 to 17 years old will also be excluded from this study to decrease the confounding variables including level of anxiety, asthma control or medication adherence. Parent: 1. Cannot communicate in Cantonese and understand Chinese; 2. Has no smartphone; 3. Participation in similar study.;
请登录查看基督教聯合醫院
/
基督教聯合醫院的其他临床试验
香港基督教聯合醫院的其他临床试验
最新临床资讯
-
Nat Rev Clin Oncol|AI赋能肿瘤临床试验:从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
